Position in ALKS
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$2,749,911
+$494,052 QoQ
Shares Held
77,769
-3.5% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PROFUND ADVISORS LLC holds $17,208,250 across 29 Drug Manufacturers - Specialty & Generic names. ALKS ranks #2 (16.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
4,687 | $2,779,297 | |
| 2 | ALKS |
Alkermes plc.
This page
|
77,769 | $2,749,911 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
17,687 | $2,330,085 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
158,462 | $1,508,558 | |
| 5 | ZTS |
Zoetis Inc.
|
6,653 | $786,451 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
22,305 | $533,758 | |
| 7 | HLN |
Haleon plc
|
50,589 | $506,395 | |
| 8 | VTRS |
Viatris Inc
|
29,453 | $397,910 |
All Filings in ALKS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,749,911 | 77,769 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $2,255,859 | 80,624 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,336,710 | 44,557 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,140,652 | 39,869 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,229,268 | 37,228 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,361,613 | 47,344 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,593,078 | 56,916 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,442,842 | 59,869 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,538,875 | 56,848 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,809,064 | 65,215 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,517,301 | 54,170 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,586,503 | 50,687 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,399,154 | 49,633 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $580,504 | 22,216 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $486,325 | 21,779 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $659,759 | 22,147 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $654,803 | 24,888 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $643,394 | 27,661 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $951,568 | 30,855 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $786,969 | 32,095 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $524,011 | 28,052 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $646,938 | 32,428 | Shares | Sole | 2021-02-09 | |
| 2020-06-30 | $682,843 | 35,180 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $426,702 | 29,591 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||